San Diego, CA, United States of America

Isabelle K Lerario

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Isabelle K. Lerario

Introduction

Isabelle K. Lerario is a prominent inventor based in San Diego, California. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds for the treatment of parasitic diseases. Her work exemplifies the intersection of innovation and healthcare, showcasing the importance of research in improving patient outcomes.

Latest Patents

Isabelle K. Lerario holds a patent for "5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases." This invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof. It also includes a method for manufacturing the compounds and their therapeutic uses. Furthermore, the invention offers a combination of pharmacologically active agents and a pharmaceutical composition. She has 1 patent to her name, reflecting her dedication to advancing medical science.

Career Highlights

Lerario is currently associated with Novartis AG, a leading global healthcare company. Her role at Novartis allows her to collaborate with other experts in the field and contribute to groundbreaking research. Her work is vital in the ongoing fight against parasitic diseases, which affect millions of people worldwide.

Collaborations

Throughout her career, Isabelle has worked alongside talented colleagues, including Jan Jiricek and Fang Liang. These collaborations have enriched her research and expanded the impact of her inventions.

Conclusion

Isabelle K. Lerario's innovative work in pharmaceutical compounds demonstrates her commitment to improving healthcare solutions. Her contributions are essential in the ongoing battle against parasitic diseases, highlighting the importance of research and collaboration in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…